CGN Relative Valuation - Cigna Group

Watchlist Manager

Watchlist

Price: 229.55 EUR 2.18% Market Closed

Market Cap: €43B

Relative Value

The Relative Value of one CGN stock under the Base Case scenario is 548.73 EUR. Compared to the current market price of 229.55 EUR, Cigna Group is Undervalued by 58%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

CGN Relative Value

Base Case

Undervaluation 58%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US	C	Cigna Group DUS:CGN	67.4B EUR	0.3	13.1	7.7	9.8
US		CVS Health Corp NYSE:CVS	90.9B USD	0.2	51.4	13.4	13.4
US		Cigna Corp NYSE:CI	69.2B USD	0.3	11.6	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	24.6B EUR	1.1	19.4	9.3	13.8
DE		Fresenius Medical Care AG XMUN:FME	22.5B EUR	1.1	23	8.9	16.4
US		Laboratory Corporation of America Holdings NYSE:LH	21.6B USD	1.5	24.6	11.9	17.2
US		Quest Diagnostics Inc NYSE:DGX	21.5B USD	1.9	21.7	11.8	15.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.5B EUR	0.5	10.8	5.2	9.7
US		Guardant Health Inc NASDAQ:GH	11.1B USD	11.3	-26.7	-29.3	-26.6
US		DaVita Inc NYSE:DVA	10.2B USD	0.8	13.7	7.1	9.7
US		Brightspring Health Services Inc NASDAQ:BTSG	7.9B USD	0	0	0	0

				Revenue Growth	P/S to Growth
US	C	Cigna Group DUS:CGN	Average P/S: 1.9 0.3	6%	0
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.1	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.5	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	1.9	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.3	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	15%	N/A

				Earnings Growth	PEG
US	C	Cigna Group DUS:CGN	Average P/E: 21.1 13.1	19%	0.7
US		CVS Health Corp NYSE:CVS	51.4	90%	0.6
US		Cigna Corp NYSE:CI	11.6	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.4	26%	0.7
DE		Fresenius Medical Care AG XMUN:FME	23	16%	1.4
US		Laboratory Corporation of America Holdings NYSE:LH	24.6	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.7	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.8	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.7	N/A	N/A
US		DaVita Inc NYSE:DVA	13.7	20%	0.7
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	30%	N/A

				EBITDA Growth	EV/EBITDA to Growth
US	C	Cigna Group DUS:CGN	Average EV/EBITDA: 9.4 7.7	4%	1.9
US		CVS Health Corp NYSE:CVS	13.4	28%	0.5
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.3	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	8.9	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	11.9	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.2	7%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.3	N/A	N/A
US		DaVita Inc NYSE:DVA	7.1	4%	1.8
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	31%	N/A

				EBIT Growth	EV/EBIT to Growth
US	C	Cigna Group DUS:CGN	Average EV/EBIT: 13.2 9.8	5%	2
US		CVS Health Corp NYSE:CVS	13.4	22%	0.6
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	13.8	12%	1.1
DE		Fresenius Medical Care AG XMUN:FME	16.4	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.2	18%	1
US		Quest Diagnostics Inc NYSE:DGX	15.9	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.7	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.6	N/A	N/A
US		DaVita Inc NYSE:DVA	9.7	5%	1.9
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	43%	N/A

Cigna Group
DUS:CGN

Relative Value

Valuation Multiples

Multiples Across Competitors

CGN Competitors Multiples
Cigna Group Competitors

See Also

Company

Help

Tools

Stocks

Cigna Group DUS:CGN

Relative Value

Valuation Multiples

Multiples Across Competitors

CGN Competitors Multiples Cigna Group Competitors

See Also

Company

Help

Tools

Stocks

Cigna Group
DUS:CGN

CGN Competitors Multiples
Cigna Group Competitors